Papers associated with tgfbr2l

???displayGene.coCitedPapers???
1 ???displayGene.morpholinoPapers???

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest

Sort Oldest To Newest

	A CRISPR-Cas9-mediated versatile method for targeted integration of a fluorescent protein gene to visualize endogenous gene expression in Xenopus laevis., Mochii M, Akizuki K, Ossaka H, Kagawa N, Umesono Y, Suzuki KT., Dev Biol. February 1, 2024; 506 42-51.
	Protocols for transgenesis at a safe harbor site in the Xenopus laevis genome using CRISPR-Cas9., Shibata Y, Okumura A, Mochii M, Suzuki KT., STAR Protoc. September 15, 2023; 4 (3): 102382.
	CRISPR/Cas9-based simple transgenesis in Xenopus laevis., Shibata Y, Suzuki M, Hirose N, Takayama A, Sanbo C, Inoue T, Umesono Y, Agata K, Ueno N, Suzuki KT, Mochii M., Dev Biol. September 1, 2022; 489 76-83.
	A mutation in TGFB3 associated with a syndrome of low muscle mass, growth retardation, distal arthrogryposis and clinical features overlapping with Marfan and Loeys-Dietz syndrome., Rienhoff HY, Yeo CY, Morissette R, Khrebtukova I, Melnick J, Luo S, Leng N, Kim YJ, Schroth G, Westwick J, Vogel H, McDonnell N, Hall JG, Whitman M., Am J Med Genet A. August 1, 2013; 161A (8): 2040-6.
	Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning., Fakhro KA, Choi M, Ware SM, Belmont JW, Towbin JA, Lifton RP, Khokha MK, Brueckner M., Proc Natl Acad Sci U S A. February 15, 2011; 108 (7): 2915-20.
	Isolation and characterization of a transforming growth factor-beta Type II receptor cDNA from Xenopus laevis., Dhanasekaran SM, Vempati UD, Kondaiah P., Gene. January 24, 2001; 263 (1-2): 171-8.
	Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer., Lücke CD, Philpott A, Metcalfe JC, Thompson AM, Hughes-Davies L, Kemp PR, Hesketh R., Cancer Res. January 15, 2001; 61 (2): 482-5.

???pagination.result.page??? 1